Clinical trial
Comparison of the Efficacy of Alpha-Blockers and Mirabegron on Symptoms Associated With Double-J Stent Implanted After Retrograde Intrarenal Surgery
NCT07018934 is registered in ClinicalTrials.gov with University of Gaziantep as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Efficacy of Alpha-Blockers and Mirabegron on Symptoms Associated With Double-J Stent Implanted After Retrograde Intrarenal Surgery
- Lead sponsor
- University of Gaziantep
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2024
- Completion date
- May 1, 2025
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ureteral stent-related symptoms